Cargando…

Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer

Mycobacteria Bovis osteomyelitis is a rare adverse effect after Bacillus Calmette-Guerin (BCG) intravesical therapy. A 62-year-old male presented with acute spinal cord compression three months after completing his second course of therapy for bladder cancer. The first course with intravesical BCG w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seegobin, Karan, Maharaj, Satish, Baldeo, Cherisse, Isache, Carmen, Gharia, Bharatsinh, Zuberi, Lara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635337/ https://www.ncbi.nlm.nih.gov/pubmed/29034173 http://dx.doi.org/10.1016/j.idcr.2017.09.008

Ejemplares similares

Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges
por: Seegobin, Karan, et al.
Publicado: (2018)

Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature
por: Gharia, Bharatsinh, et al.
Publicado: (2017)

Immune Thrombocytopenia as a Consequence of Rocky Mountain Spotted Fever
por: Baldeo, Cherisse, et al.
Publicado: (2017)

Coexistent Ipsilateral Internal Carotid Artery Occlusion and Cerebral Venous Thrombosis in Hepatitis C
por: Seegobin, Karan, et al.
Publicado: (2018)

An Aggressive Form of Langerhan Cell Histiocytosis in an Adult: Therapeutic Challenges
por: Seegobin, Karan, et al.
Publicado: (2017)

Legionnaires' Disease Complicated with Rhabdomyolysis and Acute Kidney Injury in an AIDS Patient
por: Seegobin, Karan, et al.
Publicado: (2017)

Rapid Onset of B12 Deficiency in the Setting of Worsening Multiple Myeloma: Correlations between B12 Deficiency and Multiple Myeloma
por: Seegobin, Karan, et al.
Publicado: (2017)

Bilateral Brachial Artery Disease Presenting with Features of Raynaud's Phenomenon: A Case Report and Review of the Literature
por: Seegobin, Karan, et al.
Publicado: (2017)

Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer
por: Mackel, Charles E, et al.
Publicado: (2016)

Pott’s Disease Caused by Mycobacterium bovis Following Intravesical BCG Therapy for Bladder Cancer
por: Jones, Zachary, et al.
Publicado: (2017)

Sarcoidosis presenting with facial swelling (Heerfordt syndrome)
por: Maharaj, Satish, et al.
Publicado: (2018)

A case of disseminated intravascular coagulation secondary to Acinetobacter lwoffii and Acinetobacter baumannii bacteremia
por: Baldeo, Candice, et al.
Publicado: (2015)

Necrotizing Pseudomonas aeruginosa Community-Acquired Pneumonia: A Case Report and Review of the Literature
por: Maharaj, Satish, et al.
Publicado: (2017)

Mesenteric ischemia presenting as a myocardial infarction
por: Baldeo, Cherisse, et al.
Publicado: (2018)

Fatal Type B Lactic Acidosis Associated With Metastatic Colorectal Cancer: A Case Report With Review of Literature, Pathogenesis, and Treatment
por: Gharia, Bharatsinh, et al.
Publicado: (2018)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
por: Chiu, Nan-Chang, et al.
Publicado: (2015)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder
por: Elzein, Fatehi, et al.
Publicado: (2016)

704 Mycobacterium bovis vertebral osteomyelitis due to intravesical Bacillus Calmette-Guérin (BCG): A rare complication of a common therapy
por: Sharngoe, Calden, et al.
Publicado: (2014)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy
por: Meyer, Ryan K., et al.
Publicado: (2020)

Bladder Sparing Therapy for BCG Failures – I – Intravesical Immunotherapy
por: Messing, Edward M.
Publicado: (2017)

Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)
por: Gomez, Eric, et al.
Publicado: (2009)

Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG
Publicado: (2015)

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
por: Buffen, Kathrin, et al.
Publicado: (2014)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
por: Bhat, Suresh, et al.
Publicado: (2015)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022)

Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer
por: Lukacs, S., et al.
Publicado: (2013)

Intravesical ALT-803 for BCG-unresponsive Bladder Cancer – A Case Report
por: Huang, Jeffrey, et al.
Publicado: (2017)

Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer
por: Vilares, Ana T., et al.
Publicado: (2022)

Disseminated M. bovis Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer
por: Gill, Harpreet S., et al.
Publicado: (2020)

Renal Tuberculosis Following Intravesical Bacillus Calmette–Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer
por: Bajramovic, Senad, et al.
Publicado: (2020)

Pott's disease post intravesical BCG
por: Jain, Anika
Publicado: (2023)

Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma
por: Wadhwani, Aman, et al.
Publicado: (2018)

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
por: de Jong, Joep J., et al.
Publicado: (2018)

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)

Haemophagocytic lymphohistiocytosis after intravesical BCG administration for bladder cancer presenting with multiorgan failure
por: Liatsos, G. D., et al.
Publicado: (2023)

Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer
por: Mohammed, Azharuddin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nlfpio3uojj34n7i6scpv0v6am